Skip to main content

CITADEL ADVISORS LLC

Position in XGN — Exagen Inc.

CIK 1423053 MIAMI, FL

Position in XGN

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$693,345
-$452,479 QoQ
Shares Held
231,115
+22.6% QoQ
Ownership
0.957%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2022
13 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in XGN Over Time

Shares Held

Position Value (USD)

Derivatives in XGN

reported options exposure · as of Dec 31, 2025
CallValue
$114,912
CallShares
18,900
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Diagnostics & Research

Healthcare · as of Mar 31, 2026

CITADEL ADVISORS LLC holds $1,652,977,225 across 34 Diagnostics & Research names. XGN ranks #29 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in XGN

Export CSV
29 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $693,345 231,115
2025-12-31 $1,145,824 188,458
2025-12-31 $114,912 18,900
2025-09-30 $1,277,366 116,230
2025-09-30 $152,761 13,900
2025-03-31 $66,056 18,400
2025-03-31 $12,206 3,400
2025-03-31 $15,379 4,284
2024-12-31 $26,240 6,400
2024-12-31 $4,510 1,100
2024-12-31 $91,630 22,349
2024-09-30 $1,236 400
2024-09-30 $13,905 4,500
2024-09-30 $71,097 23,009
2024-06-30 $46,189 25,379
2024-06-30 $4,550 2,500
2024-06-30 $364 200
2024-03-31 $11,511 7,240
2024-03-31 $2,544 1,600
2024-03-31 $6,519 4,100
2023-12-31 $41,262 20,735
2023-12-31 $199 100
2023-12-31 $398 200
2023-03-31 $17,496 7,200
2023-03-31 $11,664 4,800
2022-09-30 $258,805 95,500
2022-06-30 $754,810 131,500
2022-06-30 $160,696 27,996
2022-03-31 $873,664 108,800